Wikidata

(Q50122128)

English

Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial.

scientific article

In more languages

Statements

title
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21145618
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q50122128&oldid=1538378114"